1. Share Prices

  2. Niox Group PLC (NIOX)

65.20p-1.80 (-2.69%)06 Nov 2025, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Niox Group PLC Fundamentals

Company NameNiox Group PLCLast Updated2025-11-06
IndustryMedical DevicesSectorHealthcare
Shares in Issue417.879 mMarket Cap£272.46 m
PE Ratio56.78Dividend per Share£0.01
Dividend Yield1.87Dividend Cover0.76
EPS£0.01EPS Growth (%)-0.64
PEG0DPS Growth (%)0
Debt Ratio0.0169Debt Equity Ratio0.0093
Asset Equity Ratio1.1025Cash Equity Ratio0.1832
Quick Ratio3.0667Current Ratio3.73
Price To Book Value4.3478ROCE0

Niox Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2025-05-152025-06-16GBP0.0125
Prelim2024-05-232024-06-24GBP0.0100

Niox Group PLC Company Financials

Assets202420232022
Tangible Assets£1.70 m£1.40 m£1.10 m
Intangible Assets£27.80 m£32.80 m£37.10 m
Investments000
Total Fixed Assets£47.30 m£58.00 m£67.10 m
Stocks£4.00 m£4.80 m£4.10 m
Debtors£6.20 m£8.80 m£7.90 m
Cash & Equivalents£10.90 m£19.90 m£19.40 m
Other Assets000
Total Assets£68.40 m£91.50 m£98.50 m
Liabilities202420232022
Creditors within 1 year£8.10 m£7.20 m£9.20 m
Creditors after 1 year£800,000.00£500,000.00£7.40 m
Other Liabilities000
Total Liabilities£8.90 m£7.70 m£16.60 m
Net assets£59.50 m£83.80 m£81.90 m
Equity202420232022
Called up share capital£300,000.00£300,000.00£300,000.00
Share Premium£200,000.00£100,000.00£640.30 m
Profit / Loss£7.80 m£4.10 m£10.50 m
Other Equity£59.50 m£83.80 m£81.90 m
Preference & Minorities000
Total Capital Employed£59.50 m£83.80 m£81.90 m
Ratios202420232022
Debt Ratio£0.01£0.01£0.00
Debt-to-Equity£0.01£0.01£0.00
Assets / Equity1.10251.10251.1025
Cash / Equity0.18320.18320.1832
EPS£0.01£0.02£0.03
Cash Flow202420232022
Cash from operating activities£17.20 m£11.60 m£6.70 m
Cashflow before financing-£7.90 m£1.10 m£6.20 m
Increase in Cash-£8.90 m£800,000.00£6.10 m
Income202420232022
Turnover£41.80 m£36.80 m£31.30 m
Cost of sales£11.60 m£10.30 m£9.10 m
Gross Profit£30.20 m£26.50 m£22.20 m
Operating Profit£7.70 m£4.60 m£1.80 m
Pre-Tax profit£7.80 m£4.10 m£10.50 m

Niox Group PLC Company Background

SectorHealthcare
ActivitiesNIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the UnitedStates, the United Kingdom, and the Rest of the world.
Latest Interim Date30 Sep 2025
Latest Fiscal Year End Date1 Apr 2025

Niox Group PLC Directors

AppointedNamePosition
2025-05-14Mr. Michael Roy David RollerExecutive Director,Chief Financial Officer
2025-04-01Mr. Garry Watts MBENon-Executive Director,Senior Independent Director
2019-12-05Dr. Francesco GranataNon-Executive Director,Chairman
2025-06-26Mr. Ian Roy JohnsonNon-Executive Director,Chairman
2020-01-09Mr. Julien Fabrice Cotta Executive Director,Chief Financial Officer and Company Secretary
2019-12-26Mr. Steven Charles Andrew HarrisExecutive Director,Chief Executive Officer
2017-05-26Mr. Charles Stuart Webb Swingland Non-Executive Director
2016-12-16Ms. Cathrin PettyNon-Executive Director
2017-06-05Dr. Jean-Jacques GaraudNon-Executive Director
2017-05-26Dr. Timothy Henry CornNon-Executive Director
2019-08-30Dr. Rod HafnerExecutive Director,Senior Vice President, RandD
2025-07-22Mr. Jonathan Charles EmmsExecutive Director,Chief Executive Officer
2025-04-01Mr. Nicholas Harwood Bertram MillsNon-Executive Director
2025-04-11Mr. Robert Graham NaylorNon-Executive Director

Niox Group PLC Contact Details

Company NameNIOX Group PLC
AddressMagdalen Centre, Robert Robinson Avenue, Northbrook House, Oxford Science Park, Oxford, OX4 4GA
Telephone+44 1865405560
Websitehttps://www.niox.com

Niox Group PLC Advisors

StockbrokerNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
BankHSBC Bank PLC
Remuneration ConsultantNew Bridge Street
Phone+44 2070868000
Fax+44 2076211511
StockbrokerJ.P. Morgan Cazenove Ltd
Phone+44 2077424000
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
SolicitorAllen & Overy LLP
Phone+44 2030880000
Fax+44 207339999
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
RegistrarEquiniti Limited

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Helios Towers PLC171.8010.84
Rs Group PLC595.007.69
Sainsbury (J) PLC355.805.52
Osb Group PLC552.505.04
Hochschild Mining PLC336.404.93
Energean PLC1,023.003.75

Fallers

CompanyPrice% Chg
Hikma Pharmaceuticals PLC1,522.00-14.06
Tbc Bank Group PLC3,785.00-11.87
Smith & Nephew PLC1,242.00-10.87
Goodwin PLC21,200.00-9.01
Ashmore Group PLC170.80-8.86
Diageo PLC1,680.00-6.54